Water balance in the Brattleboro rat: single or multiple defects?
The total restoration of urinary concentrating ability of the DI rat given daily injections of vasopressin takes several weeks, although complete osmotic equilibrium across the collecting duct is manifest within hours. This suggests that there may be other deficiencies of the renal concentrating mechanism that, if corrected by vasopressin treatment, are corrected more slowly. I have focussed on just three possibilities. First, the morphology of the medullary interstitium is different from normal rats. Perhaps associated with this finding are alterations in the levels of medullary glycosaminoglycans which may have a role to play in water balance. Functional and morphological changes in the juxtamedullary nephrons are also evident. Second, the possibility exists that the countercurrent multiplier of the DI rat operates less efficiently than in the normal animal. Finally, reduced synthesis of PGs in the renal medulla of DI rats may also influence the concentrating mechanism, although in a favorable direction. While most (if not all) of these differences are secondary to the lack of vasopressin, in some instances it appears that it is the high water turnover (possibly the altered chemical composition of the medullary interstitium) that is the primary culprit. While the DI rat remains an excellent model for the study of water balance and the action of vasopressin, the presence of multiple defects within the system should be borne in mind. This is particularly true when comparing data obtained following acute treatment with vasopressin versus that following chronic treatment.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D003919:Diabetes Insipidus / Q000503:physiopathology; D004195:Disease Models, Animal; D005919:Glomerular Filtration Rate; D006025:Glycosaminoglycans / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007671:Kidney Concentrating Ability / Q000187:drug effects; D007679:Kidney Medulla / Q000378:metabolism / Q000473:pathology; D008138:Loop of Henle / Q000187:drug effects / Q000502:physiology; D009399:Nephrons / Q000473:pathology; D009994:Osmolar Concentration; D011453:Prostaglandins / Q000378:metabolism; D051381:Rats; D011910:Rats, Brattleboro / Q000502:physiology*; D011922:Rats, Mutant Strains / Q000502:physiology*; D014667:Vasopressins / Q000172:deficiency / Q000494:pharmacology; D014883:Water-Electrolyte Imbalance / Q000473:pathology / Q000503:physiopathology*
D006025:Glycosaminoglycans; D011453:Prostaglandins; C016671:pitressin tannate; D014667:Vasopressins; D001127:Arginine Vasopressin; D000262:Adenylyl Cyclases; D003894:Deamino Arginine Vasopressin